Preliminary Itinerary

facebook logo
Like and share us on:
facebook logotwitter-logo-4.pnginstagram logo

Day 1 Thursday, September 20, 2018

13:00 - 14:00


14:00 - 14:10

Soft Opening

Discussion Forum 1

14:30 - 15:30

Topic 1 : How to build Hong Kong and the Greater Bay Area into an Asian Biotechnology Hub

15:30 - 16:00

Coffee Break

Discussion Forum 2

16:00 - 18:00

Topic 2 : How to build and evaluate your biotechnology company so it can be eventually listed in HKEx and US NASDAQ


Day 2 Friday, September 21, 2018

6:00 - 9:00

**Transportation – From HK to Shenzhen

8:50 - 9:00

2018 BT Opening

Prof. Guo-Ying Zhou - CEO President of Shenzhen International Institute for Biomedical Research

CEO of Immvira Co.,Limited

Session 1 Drug Development and Future Prospect

9:00 - 9:35

Dr. Christine Gulbranson - SVP, Chief Innovation Officer for Innovation & Entrepreneurship for the University of California System

Topic: An inside look into the University of California's Drug Development and Commercialization


9:45 - 10:20

Dr. Jing Ma - President of Shanghai InnoStar Bio-Tech Co. Ltd (National Shanghai Center for New Drug Safety Evaluation and Research)

Topic: Strategy and challenge of Non-clinical evaluation for Cell Therapy Products


10:30 - 11:05

Dr. Jean-Simon Diallo - Assistant Professor of Biochemistry Microbiology and Immunology Department of the University of Ottawa

Topic: Viral Sensitizer Technology

Jean Simon Diallo2

11:15 - 11:50

Dr. Dongyao Ni - Chief Medical Officer of Immvira Co., Limited

Topic: Development of New Generation Oncolytic Virus and Future Prospect


11:50 - 13:30



Session 2 Industrialization of New Drug Development

13:40 - 14:15

Dr. Lan Zhang - Director of Department of Pharmacy at Xuanwu Hospital of Capital Medical University

Deputy Director of the National Drug Clinical Trial Institute

Topic: R&D of Taisi for Alzheimer's Disease —from Pre-Clinical to Clinical

Lan Zhang 2

14:25 - 15:00

Dr. Yue Han - Director of Business Department in CantonBio

Topic: Value Creation in Biological Product Development

Yue Han.jpg

15:10 - 15:45

Dr. Zhao Xiaoping - Senior Director of Pharmacokinetics and Bioanalysis at Shanghai InnoStar Bio-Tech Co. Ltd (National Shanghai Center for New Drug Safety Evaluation and Research)

Topic: Actuality, Challenges and Solution of Immunogenicity Evaluation


16:00 - 18:00

Transportation (From Shenzhen to HK)


18:00 - 19:00



Discussion Forum 3

19:00 - 21:00

Topic: China-US Trade War - How does it affect biotechnology and pharmaceutical industry locally, nationally and globally?


**This is a self funded item/event which is not related to the grant provided by Professional Services Advancement Support Scheme (“PASS”) from The Commerce and Economic Development Bureau. Any extra charges are for participants to reserve goods and services, and no profit will be generated from the packages to us.


Day 3 Saturday, September 22, 2018

9:00 - 9:30

Grand Open Ceremony

Session 3 Biotechnology Development

9:30 - 10:30

Keynote Speaker: Prof. Lu Li

Director of the Department of Educational, Scientific and Technological Affairs, Liaison Office of the Central People's Government in the HKSAR

Topic: All about GD/HK/MO Greater Bay Area

Prof Li Lu

Dr. Monica He - Director of international affairs at Biotechnology Innovation Organization (BIO)

Topic: Global Perspective on Biotech Innovation

Monica He

10:30 - 10:45

Coffee Break


Session 4 Immunotherapy

10:45 - 13:00

Special Guest Speech - TBC


Prof. Ken Yung - Professor and Associate Head
Faculty of Science, Hong Kong Baptist University

Topic: Neural Stem Cell Technology as a potential treatments of Neurodegenerations


Prof. Gong ChenProfessor at Department of Biology at Pennsylvania State University
Lab Head of Charles H. "Skip" Smith Life Sciences Laboratory
Verne M. Willaman Chair in Life Sciences

Topic: Brain repair via in Situ Astrocyte-to-Neuron Conversion

Gong Chen2

Dr. Jian Ni - President of R&D and CSO of Nuance Biotech Inc.

Topic: CBA introduction

New Immunomodulatory targets and next generation active immune checkpoint control immunotherapy

Jian Ni2

Dr. Lynda Chin - Founder, CEO of Apricity Health LLC

Professor of Medicine, Dell Medical School UT Austin

Topic: Transforming Medicine with Data, Analytics and Technologies


13:00 - 14:10



 Session 5 Chinese Medicine

14:10 - 15:10

Special Guest Speech - TBC


Dr. Lan Zhang - Director of Department of Pharmacy at Xuanwu Hospital of Capital Medical University

Deputy Director of the National Drug Clinical Trial Institute
Topic: Current situation and practice of Chinese Natural Medicine and New drug development of Traditional Chinese Medicine

 Lan Zhang 2

Dr. Imran Khan - Macau University of Science and technology

Topic: The anti-cancer nexus of Chinese medicine and gut microbiota

Profile PIC 2017 2

Session 6 Cancer

15:10 - 16:25

Dr. Peter Lin - Cytelligen

Topic: Detection and clinical significance of Aneuploid CTCs and CECs

Peter Lin

Prof. Pui-Kwong ChanDepartment of pharmacology, Baylor College of Medicine, Houston

Topic: Development of herbal saponin into anticancer drugs and new saponins library

puikwongchanphoto 5b5bd76946044

Dr. Mao Mao - Chief Executive Officer of SeekIn
Topic: How can cancer mortality be reduced by early detection

Mao Mao

16:25 - 16:40

Coffee Break

Session 7 Diagnostic

16:45 - 19:00

Special Guest Speech - TBC


Key Note Speaker: Prof. Richard Barker -

Founding Director of New Medicine Partners
Founding Director of Centre for the Advancement of Sustainable Medical Innovation (CASMI)

Topic: Translational science in the era of precision medicine

Richard Barker

Dr. Zhaoyang Ye - Chief Scientific Officer of Hai Kang Life Corp Limited

Topic: Multiplexing Molecular Diagnostics for Point-of-Care Application in Infectious Diseases

Dr Ye

Dr. Sitong Sheng - Founder of Shenzhen HYK Gene technology
Topic: NGS accelerates precision medicine

Sitong Sheng

Dr. Nikolay Sergeev - Founder and CTO of AlteraBio

Topic: Liquid Biopsy - Promises and Current Challenges

NikolayEdited2 face

Dr. Jason Zhu - CEO of InnoMedi Inc.
Topic: iHeart - Long term Cardiac Patch - ECG Collection & Analysis

Jason Pic2



Day 4 Sunday, September 23, 2018

Session 8 Pharmaceutical Development

9:00 - 10:30

Keynote Speaker: Prof. Wang Yu

Former Director General of Chinese Center for Disease Control and Prevention (China CDC)
Member of the Advisory Committee of China's New Urbanization Research Experts at Tsinghua University

Topic: The prospect of bio-medicine industry in transitional China

WhatsApp Image 2018 08 08 at 12.20.02

Keynote Speaker: Dr. Shun Luo

Founder and President of Jianshun Biosciences Co., Ltd. and Thousand Oaks Biopharmaceuticals Co., Ltd.

Topic: The future of Biopharmaceutical Industry - The future is here

Picture ShunLuo

10:30 - 10:40

Coffee Break


Session 9 Business Opportunity in Biotechnology

10:40 - 13:00

Ms.Mabel Chu- Independent Commission Against Corruption (ICAC)

Topic: Integrity – The Key to Business Success


Ms. Diana Viola - Chief Executive Officer of PharmaBoardroom

Topic: GBA biotech and medical technology

 Diana Viola2

Dr. Dan Zhang - Executive chairman of Fountain Medical Development Ltd

Topic: Product Development and IPO in the Era of ICH

Dan Zhang2

Mr. Eugene Yeoh - Co-Head, IPO Vetting Team, Hong Kong Exchanges & Clearing Limited (HKEX)

Topic: Enhancing Hong Kong's listing framework - Listing regime for Biotech Companies

Eugene Yeoh 187 bio2

Dr. Jimmy Zhang - Venture Partner, LAV (Lilly Asia Ventures)

Topic: How to attract investments from VCs

Zhang Jimmy2

13:00 – 14:00



Session 10 Oncology and Gene Therapy  

14:00 – 15:30

Dr. Alan Lu - Founder, president and CEO of Sirnaomics Inc.

Topic: Novel siRNA Therapeutics for Immune Oncology Application with Polypeptide Nanoparticle Delivery Technology


Dr. Zhenhua Wu - President of Sino-American Pharmaceutical Professionals Association Greater Philadelphia
Chief Executive Officer of NeuExcell Therapeutics Inc.

Topic: A transformative gene therapy for neurodegenerative diseases

Zhenhua Wu

Dr. Ruhong Jiang - Chairman CEO and President of Applied StemCells

Topic: How soon can we move Gene editing therapy - Gene therapy 2.0 to the clinic

Ruhong Jiang

Dr. Harry Liu - Senior medical director in Genentech/Roche

Topic: Evaluating the Benefit: Risk of Oncology molecules from a clinical perspective

Harry Liu2

Session 11 Sustainable Development and Support on Biotechnology

15:30 – 17:00

Dr. Michael Wang - Chief Strategy Officer for Alliances and Partnerships
National Foundation for Cancer Research (NFCR)

Topic: Developing sustainable support for translational cancer cures research

Michael Wang

Mr. Liedong Xu - President and Chief Executive Officer of Rundo International Pharmaceutical Research & Development Co., Ltd.

Topic: The Important Role of CROs in New Drug Development

LieDong Xu

Dr. Jian Han - Founder, Chairman of the Board, President and Chief Scientific Officer

Topic: Why there is no KillerApp in molecular diagnostics

Jian Han2

Mr. Ronald Pong - Smart City Consortium - IT Governance Committee Chairman
Topic: Health Care IOT Security

Ronald Pong

17:00 – 17:15

Coffee Break


Session 11 Knowledge Exchange Session

17:15 – 19:00

Mr. Brett CooperGeneral Manager, Hong Kong and Macau, Philip Morris Asia Limited

Topic: Innovation in Heat-not-burn technology applying in tobacco products to reduce risk of harm

Brett Cooper.png

Mr. Jon Chang - Co-founder of Asia Microbiota Bank

Topic: Microbiome: the Science Disrupting Drug Discovery

Jon Chang

Dr. Sandy Kwok- Assistant Chief Scientific Officer of Hai Kang Life Corporation Limited

Topic: The Diagnostic Revolution: A total Solution via EFADchip x BioRadar Technology

Sandy Kwok

Mr. Roger Wu – Co-founder of Ginko Dochong Assest Management Ltd, Co-founder of WS Capital Management Ltd

Manager of Jiangsu Government Investment Fund


19:00 - 19:20

Closing Ceremony

Click here for program book


Founded by pioneering scientists with extensive life science backgrounds and multi-cultural experience in research and development, engineering and business, the vision of the Hong Kong Biotechnology Organization is to establish and facilitate a worldwide platform for the Hong Kong biotech industry, promoting awareness, encouraging and enabling international collaboration and providing informed opinion and technical advice to government bodies, healthcare institutions and the general public.

Contact Us

Telephone:  +852 2799 7688
+86 10 87128986 (Ms Zhihui YIN - Beijing)
Fax:  +852 2111 9762
Email:  info@hkbio.org.hk
Mail:  Units 601-605, 6/F, Biotech Centre One,
9 Science Park West Avenue,
Hong Kong Science Park, Shatin,
New Territories, Hong Kong

此刊物/本項目由香港特別行政區政府「專業服務協進支援計劃」撥款資助 。
This material / event is funded by the Professional Services Advancement Support Scheme of the Government of the Hong Kong Special Administrative Region.

Any opinions, findings, conclusions or recommendations expressed in this material/any event organised under this project do not reflect the views of the Government of the Hong Kong Special Administrative Region or the Vetting Committee of the Professional Services Advancement Support Scheme.